20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Financial giants have made a conspicuous bearish move on Bristol-Myers Squibb. Our analysis of options history for Bristol-Myers Squibb (NYSE:BMY) revealed 8 unusual trades.
Delving into the details, we found 25% of traders were bullish, while 75% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $518,424, and 3 were calls, valued at $128,180.
What's The Price Target?
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $52.0 to $60.0 for Bristol-Myers Squibb over the recent three months.
Volume & Open Interest Trends
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Bristol-Myers Squibb's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Bristol-Myers Squibb's significant trades, within a strike price range of $52.0 to $60.0, over the past month.
Bristol-Myers Squibb 30-Day Option Volume & Interest Snapshot
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| BMY | PUT | SWEEP | BEARISH | 09/20/24 | $60.00 | $188.1K | 178 | 257 |
| BMY | PUT | SWEEP | BEARISH | 08/16/24 | $60.00 | $180.8K | 73 | 254 |
| BMY | PUT | SWEEP | BEARISH | 08/16/24 | $57.50 | $71.7K | 224 | 135 |
| BMY | CALL | SWEEP | BEARISH | 05/17/24 | $52.50 | $47.2K | 8.5K | 304 |
| BMY | CALL | SWEEP | BULLISH | 03/28/24 | $52.00 | $43.1K | 342 | 0 |
About Bristol-Myers Squibb
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
After a thorough review of the options trading surrounding Bristol-Myers Squibb, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Present Market Standing of Bristol-Myers Squibb
- Trading volume stands at 4,506,469, with BMY's price up by 0.04%, positioned at $54.38.
- RSI indicators show the stock to be may be overbought.
- Earnings announcement expected in 44 days.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Bristol-Myers Squibb, Benzinga Pro gives you real-time options trades alerts.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!